DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

SMS Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 36 min ago·10 Sept 2026, 9:43 am

SMS Pharmaceuticals

SMS Pharmaceuticals has informed stock exchanges about its upcoming analyst and institutional investor meetings. This announcement signals that the company is preparing to discuss its recent performance and future outlook with financial experts and large investors.

For investors, these meetings are a key opportunity to gain direct insights into the company's strategy and operational health. Management often uses this platform to address market concerns or highlight growth drivers, which can provide clarity on the stock's near-term trajectory.

Investors should watch for any updates on product pipelines, export orders, or margin guidance shared during these sessions. This information will be crucial for assessing the company's competitive position and long-term potential.